Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK.
Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
Schizophr Res. 2021 Feb;228:29-35. doi: 10.1016/j.schres.2020.11.060. Epub 2021 Jan 9.
While Cognitive Remediation (CR) is effective in reducing cognitive and functioning difficulties in people with schizophrenia, there is variability in treatment response. Previous research suggested that participants' age may be a significant moderator of CR response.
To examine the impact of participants' age on CR outcomes.
Individual participant data were accessed from fourteen CR randomised controlled trials. We tested the moderating effect of participants' age on cognitive and functioning outcomes using multivariate linear models.
Data from 1084 people with a diagnosis of schizophrenia were considered. Participants had a mean age of 36.6 years (SD 11), with 11.6 years of education (SD 2.8), and an average duration of illness of 13.5 years (SD 10.7). Multivariate models showed that participants' age, when considered as a continuous variable, was not a significant moderator of treatment effect for cognitive and functioning outcomes. However, when participants were split by median age, younger participants showed higher gains in executive functions following CR compared to older participants (p=0.02).
These results suggest that participants' age does not moderate most CR outcomes. However, larger age differences may influence the effect of CR on executive function. This may suggest some adaptation of CR practice according to participants' age. These findings inform the CR personalisation agenda.
认知矫正(CR)在减少精神分裂症患者的认知和功能障碍方面非常有效,但治疗反应存在差异。先前的研究表明,参与者的年龄可能是 CR 反应的重要调节因素。
探讨参与者年龄对 CR 结果的影响。
从 14 项 CR 随机对照试验中获取了个体参与者数据。我们使用多元线性模型测试了参与者年龄对认知和功能结果的调节作用。
共考虑了 1084 名精神分裂症诊断患者的数据。参与者的平均年龄为 36.6 岁(SD 11),受教育年限为 11.6 年(SD 2.8),平均病程为 13.5 年(SD 10.7)。多元模型显示,参与者的年龄作为连续变量时,并不是认知和功能结果治疗效果的显著调节因素。然而,当参与者按中位数年龄分组时,与年龄较大的参与者相比,年龄较小的参与者在接受 CR 后执行功能方面的增益更高(p=0.02)。
这些结果表明,参与者的年龄不会调节大多数 CR 结果。然而,较大的年龄差异可能会影响 CR 对执行功能的影响。这可能表明根据参与者的年龄对 CR 实践进行一些调整。这些发现为 CR 个性化议程提供了信息。